Clinical Trial Update: A Study in Moderate to Severe Rheumatoid Arthritis Participants [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in moderate to severe rheumatoid arthritis completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-06-12